Skip to content

Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD

Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07784348
Enrollment
120
Registered
2026-08-25
Start date
2024-05-01
Completion date
2030-12-01
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Keywords

ADHD, Central Executive Training, Behavioral Parent Training

Brief summary

Initial non-randomized trial of behavioral parent training (BPT) compared to central executive training (CET), followed by a randomized controlled trial of CET+BPT for young children with ADHD.

Detailed description

Initial non-randomized trial of behavioral parent training (BPT) compared to central executive training (CET) \[R61 Phase\], followed by a randomized controlled trial of CET+BPT for young children with ADHD \[R33 Phase\].

Interventions

BEHAVIORALCentral executive training

Computerized, adaptive central executive working memory training protocol

Behavioral parent training

Sponsors

Florida State University
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* principal ADHD diagnoses (via K-SADS); (b) parent BASC-3 ADHD Problems or ADHD-RS ADHD-Combined scale in clinical/borderline range (\>90th percentile) based on age and sex; (c) teacher BASC-3 ADHD Problems or ADHD-RS ADHD-Combined scale in clinical/borderline range based on age and sex

Exclusion criteria

* (a) gross neurological, sensory, or motor impairment; (b) history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with study participation (e.g., disruptive mood dysregulation, conduct, intermittent explosive, reactive attachment); (c) intellectual disability or WPPSI/WISC short-form FSIQ\<70; (d) conditions requiring acute intervention, e.g., active suicidality; and (e) non-English speaking child or parent.

Design outcomes

Primary

MeasureTime frame
ADHD Rating Scale (ADHD-RS)Change from baseline to immediate post-treatment and maintenance of gains up to 3 months after treatment completion

Secondary

MeasureTime frameDescription
Secondary outcomes (T-scores)Change from baseline to immediate post-treatment and maintenance of gains up to 3 months after treatment completionInformant reports of social skills, emotion regulation, parent-child relationships, and impairments
Feasibility/acceptabilityChange from baseline to immediate post-treatment and maintenance of gains up to 3 months after treatment completionClient satisfaction, system usability, expectancies

Countries

United States

Contacts

CONTACTChildren's Learning Clinic
clc@psy.fsu.edu850-645-7423
PRINCIPAL_INVESTIGATORMichael Kofler, PhD

Florida State University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026